The CEO of CME, Terrence Duffy, has announced plans to file a lawsuit against the Commodity Futures Trading Commission (CFTC) following its recent approval of perpetual futures products, specifically those offered by Kalshi.
Duffy contends that these products violate the Dodd-Frank Act's definition of a swap, which he discusses in a recent CNBC interview. He argues that the approval of products that essentially function as swaps requires compliance with a different regulatory framework than that applied to futures contracts.
As he prepares to step down next year, Duffy emphasized the need for clarity in the regulatory environment before CME can consider launching its own perpetual futures contracts. "The current guidelines are not very clear," he remarked, highlighting the complexities surrounding the classification of these financial instruments.
